Abrahamsen B - Search Results

1

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.

Abrahamsen B, Pazianas M, Russell RG. Abrahamsen B, et al. BMJ. 2013 Mar 12;346:f1514. doi: 10.1136/bmj.f1514. BMJ. 2013. PMID: 23482976 No abstract available.

2

Safety of bisphosphonates.

Pazianas M, Abrahamsen B. Pazianas M, et al. Among authors: abrahamsen b. Bone. 2011 Jul;49(1):103-10. doi: 10.1016/j.bone.2011.01.003. Epub 2011 Jan 12. Bone. 2011. PMID: 21236370 Review.

3

Esophageal and gastric cancer incidence and mortality in alendronate users.

Abrahamsen B, Pazianas M, Eiken P, Russell RG, Eastell R. Abrahamsen B, et al. J Bone Miner Res. 2012 Mar;27(3):679-86. doi: 10.1002/jbmr.1481. J Bone Miner Res. 2012. PMID: 22113985 Free article.

4

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.

Pazianas M, Abrahamsen B, Eiken PA, Eastell R, Russell RG. Pazianas M, et al. Among authors: abrahamsen b. Osteoporos Int. 2012 Nov;23(11):2693-701. doi: 10.1007/s00198-012-1902-4. Epub 2012 Mar 6. Osteoporos Int. 2012. PMID: 22392160

5

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.

Pazianas M, Abrahamsen B, Wang Y, Russell RG. Pazianas M, et al. Among authors: abrahamsen b. Osteoporos Int. 2012 Dec;23(12):2873-84. doi: 10.1007/s00198-012-1952-7. Epub 2012 Mar 20. Osteoporos Int. 2012. PMID: 22431012

6

Bisphosphonates and colon cancer: reply.

Pazianas M, Abrahamsen B, Eiken PA, Eastell R, Russell RG. Pazianas M, et al. Among authors: abrahamsen b. Osteoporos Int. 2013 Mar;24(3):1141-2. doi: 10.1007/s00198-012-2079-6. Epub 2012 Jul 31. Osteoporos Int. 2013. PMID: 22847317 No abstract available.

7

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.

Pazianas M, Clark EM, Eiken PA, Brixen K, Abrahamsen B. Pazianas M, et al. Among authors: abrahamsen b. J Bone Miner Res. 2013 Mar;28(3):455-63. doi: 10.1002/jbmr.1783. J Bone Miner Res. 2013. PMID: 23044864 Free article.

8

Safety issues with bisphosphonate therapy for osteoporosis.

Suresh E, Pazianas M, Abrahamsen B. Suresh E, et al. Among authors: abrahamsen b. Rheumatology (Oxford). 2014 Jan;53(1):19-31. doi: 10.1093/rheumatology/ket236. Epub 2013 Jul 9. Rheumatology (Oxford). 2014. PMID: 23838024 Review.

9

Eliminating the need for fasting with oral administration of bisphosphonates.

Pazianas M, Abrahamsen B, Ferrari S, Russell RG. Pazianas M, et al. Among authors: abrahamsen b. Ther Clin Risk Manag. 2013;9:395-402. doi: 10.2147/TCRM.S52291. Epub 2013 Oct 18. Ther Clin Risk Manag. 2013. PMID: 24204155 Free PMC article.

10

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.

Pazianas M, Abrahamsen B. Pazianas M, et al. Among authors: abrahamsen b. Osteoporos Int. 2014 Nov;25(11):2669. doi: 10.1007/s00198-014-2788-0. Epub 2014 Jul 18. Osteoporos Int. 2014. PMID: 25035137 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters